|

Anthracycline Clinical Trials

4 actively recruiting trials

No change since May 2026

Also known as: Doxil, Lipodox

Pipeline

Phase 2: 3

Top Sponsors

  • Shandong Cancer Hospital and Institute1
  • Ruijin Hospital1
  • Guangdong Provincial People's Hospital1
  • Centre Paul Strauss1

Indications

Other4 trials

Organoid-based Functional Precision Therapy for Advanced Breast Cancer
Phase 2
Posaconazole Plus PD-1 Inhibitors and Chemotherapy vs PD-1 Inhibitors and Chemotherapy in Neoadjuvant Therapy for Triple Negative Breast Cancer
Phase 2
Role of Sodium-glucose Linked Transporter 2 (SGLT2) and Its Inhibitor Over CARdiotoxicity Induced by Anthracyclines and Breast Cancer Tumorigenesis SCARA-B
Study of SA+X in the Treatment of Newly Diagnosed AML
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.